Trade

Sotac Pharmaceuticals share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 118.30(0.00%)
    January 30, 2026 15:40:00 PM IST
    • NSE
    • BSE
  • Vol : 0 (NSE + BSE)
    Last 20 day avg : 3.60 K

Sotac Pharmaceuticals is trading 0.00% upper at Rs 118.30 as compared to its last closing price. Sotac Pharmaceuticals has been trading in the price range of 0.00 & 0.00. Sotac Pharmaceuticals has given -3.90% in this year & 0.00% in the last 5 days. Sotac Pharmaceuticals has TTM P/E ratio 13.73 as compared to the sector P/E of 23.40.Listed peers of Sotac Pharmaceuticals include Divi's Laboratories (-1.78%), Cipla (-0.14%), Sun Pharmaceutical Industries (-0.43%).The Mutual Fund holding in Sotac Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sotac Pharmaceuticals was at 16.14% in 30 Sep 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 08, 2026, 02:38 PM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.82
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.08
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.37
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
0.00
Highest
0.00
52 week range
Lowest
88.05
Highest
152.35
Sotac Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Bearish
6,027.00-1.781,60,509.2872.7410.660.500.01
Cipla
Moderately Bearish
1,330.80-0.141,07,490.2120.173.40.990.81
Sun Pharmaceutical Industries
Neutral
1,694.90-0.434,06,653.7034.055.420.980.50
Torrent Pharmaceuticals
Neutral
3,931.65-1.041,33,059.5569.0417.530.8117.62
Dr Reddy's Laboratories
Neutral
1,241.60-0.291,03,622.8618.183.060.652.34
Sotac Pharmaceuticals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-12Quarterly Results & Others
2025-05-28Audited Results, Dividend & Others
2024-10-29Quarterly Results
2024-08-13Quarterly Results
2024-05-17Audited Results & Others
About the company Sotac Pharmaceuticals
  • IndustryBiotechnology & Drugs
  • ISININE0O2D01012
  • BSE Code
  • NSE CodeSOTAC
Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.
  • Management Info
  • Sharadkumar PatelManaging Director, Executive Chairman
  • Brijeshkumar PatelChief Financial Officer
  • Pankaj MahabaleshwarkarChief Operating Officer
  • Niyati ParikhChief Compliance Officer, Company Secretary
  • Dineshkumar GelotWhole Time Director
  • Chetankumar PatelExecutive Director
  • Vishalkumar PatelExecutive Director
Sotac Pharmaceuticals Share Price FAQs

Sotac Pharmaceuticals is trading at 118.30 as on Fri Jan 30 2026 10:10:00. This is 0.00% upper as compared to its previous closing price of 118.30.

The market capitalization of Sotac Pharmaceuticals is 130.72 Cr as on Fri Jan 30 2026 10:10:00.

The 52 wk high for Sotac Pharmaceuticals is 152.35 whereas the 52 wk low is 88.05

Sotac Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 13.73
  • Sector P/E: 23.40
  • Dividend Yield: 0.08%
  • D/E ratio: 0.69

Sotac Pharmaceuticals reported a net profit of 8.03 Cr in 2025.